Free Trial

Innospec (NASDAQ:IOSP) Releases Quarterly Earnings Results, Beats Expectations By $0.05 EPS

Innospec logo with Basic Materials background

Innospec (NASDAQ:IOSP - Get Free Report) issued its quarterly earnings data on Tuesday. The specialty chemicals company reported $1.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.36 by $0.05, Zacks reports. The firm had revenue of $466.80 million during the quarter, compared to the consensus estimate of $447.43 million. Innospec had a net margin of 1.93% and a return on equity of 12.27%.

Innospec Price Performance

NASDAQ:IOSP traded up $0.31 during mid-day trading on Friday, reaching $103.46. The stock had a trading volume of 281,005 shares, compared to its average volume of 130,141. The stock has a 50-day simple moving average of $110.87 and a two-hundred day simple moving average of $112.43. The stock has a market capitalization of $2.58 billion, a PE ratio of 72.86 and a beta of 1.09. Innospec has a 12 month low of $99.49 and a 12 month high of $133.71.

Analysts Set New Price Targets

Separately, StockNews.com downgraded shares of Innospec from a "strong-buy" rating to a "buy" rating in a research report on Saturday, January 11th.

Get Our Latest Stock Analysis on Innospec

Innospec Company Profile

(Get Free Report)

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.

Featured Stories

Earnings History for Innospec (NASDAQ:IOSP)

Should You Invest $1,000 in Innospec Right Now?

Before you consider Innospec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.

While Innospec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines